Charles Cherington

Insider Reports History

Entity
Individual
Location
One Bow Street, Cambridge, MA
Signature
/s/ Charles Cherington
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Cherington:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. 10%+ Owner Common Stock 20.4M $10.2M $0.50 Apr 2, 2025 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Warrants to Purchase Common Stock 20.7M $5.16M $0.25 Dec 29, 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 5.81M $412K $0.07 Sep 11, 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 1.27M $89.8K $0.07 Sep 11, 2023 By LLC
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 95.3K $6.75K $0.07 Sep 11, 2023 By trust
Eterna Therapeutics Inc. 10%+ Owner Warrants (right to buy) 0 $0 $0.13 Oct 29, 2024 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Series A Convertible Perpetual Preferred Stock 3.9K Dec 27, 2023 By LLC
Eterna Therapeutics Inc. 10%+ Owner 12.0% Senior Convertible Notes due December 12, 2028 0 Oct 29, 2024 Direct
Eterna Therapeutics Inc. 10%+ Owner 12.0% Senior Convertible Notes due September 24, 2025 0 Oct 29, 2024 Direct
Eterna Therapeutics Inc. 10%+ Owner 6.0% Senior Convertible Promissory Notes due 2028 0 Oct 29, 2024 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner 12.0% Senior Secured Convertible Notes $568K Dec 29, 2023 Direct

Insider Reports Filed by Charles Cherington

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ERNA Eterna Therapeutics Inc. Apr 2, 2025 1 $394K 4 Apr 4, 2025 10%+ Owner
ERNA Eterna Therapeutics Inc. Sep 23, 2024 17 -$4.89M 4 Nov 5, 2024 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Dec 27, 2023 3 $1.95B 4 Jan 3, 2024 10%+ Owner
ERNA Eterna Therapeutics Inc. Dec 14, 2023 6 $3.39M 4 Dec 20, 2023 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Sep 11, 2023 2 $1.05M 4 Sep 11, 2023 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Jul 31, 2023 2 $450K 4 Aug 25, 2023 10%+ Owner
ERNA Eterna Therapeutics Inc. Jul 13, 2023 2 $3.59M 4 Aug 25, 2023 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Jan 4, 2023 2 $1.1M 4 Jan 6, 2023 10%+ Owner
ERNA Eterna Therapeutics Inc. Dec 2, 2022 2 $924K 4 Dec 6, 2022 Director, 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Oct 20, 2022 2 $23.7K 4 Oct 24, 2022 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Oct 14, 2022 2 $32.2K 4 Oct 18, 2022 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Oct 13, 2022 1 $17.4K 4 Oct 14, 2022 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Sep 29, 2022 1 $33.5K 4 Sep 30, 2022 10%+ Owner
CMRA Comera Life Sciences Holdings, Inc. Sep 27, 2022 1 $20.2K 4 Sep 29, 2022 10%+ Owner
ERNA Brooklyn ImmunoTherapeutics, Inc. Aug 1, 2022 2 $0 4 Aug 3, 2022 Director
CMRA Comera Life Sciences Holdings, Inc. May 19, 2022 0 $0 3 Sep 14, 2022 10%+ Owner
ERNA Brooklyn ImmunoTherapeutics, Inc. Dec 8, 2021 2 $0 4 Dec 10, 2021 Director
BRD Beard Energy Transition Acquisition Corp. Nov 23, 2021 0 $0 3 Nov 23, 2021 Director
ERNA Brooklyn ImmunoTherapeutics, Inc. Jun 16, 2021 3 -$6.3M 4 Jun 21, 2021 Director, 10%+ Owner